av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

23.26

06/11 21:01

Market Cap

2.41B

Beta: 2.11

Volume Today

599.89K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

OverviewFinancialsAPI

    Description

    Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-072020-08-062021-12-312023-08-082024-11-07

    Revenue (Estimate*)

    1M2M3M4M2019-03-072020-08-062021-12-312023-08-082024-11-07

    *Estimate based on analyst consensus